Assessment of adverse effects and applicability – two areas not (yet) covered adequately in Cochrane reports
- 1 January 2008
- journal article
- Published by Elsevier BV in Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
- Vol. 102 (8), 497-502
- https://doi.org/10.1016/j.zefq.2008.08.028
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic reviewBMJ, 2006
- The Cochrane CollaborationEuropean Journal of Clinical Nutrition, 2005
- Challenges in Systematic Reviews That Evaluate Drug Efficacy or EffectivenessAnnals of Internal Medicine, 2005
- Challenges in Systematic Reviews That Assess Treatment HarmsAnnals of Internal Medicine, 2005
- Challenges in Systematic Reviews of Therapeutic Devices and ProceduresAnnals of Internal Medicine, 2005
- Availability of large-scale evidence on specific harms from systematic reviews of randomized trialsThe American Journal of Medicine, 2004
- The road to health careBMJ, 2004
- Balancing benefits and harms in health careBMJ, 2003
- Assessment of therapeutic safety in systematic reviews: literature reviewBMJ, 2001
- REVIEWING THE REVIEWSInternational Journal of Technology Assessment in Health Care, 2001